Infectious Diseases II: Bacterial Infections Flashcards
Perioperative Antibiotic Prophylaxis
Bug and Drug of Choice, Alternatives
Bug: Staphylococci and Streptococci
——Drugs——–
DOC: Cefazolin*** or Cefuroxime
Alt: Vancomycin or Clindamycin
- used when a beta-lactam allergy or risk of MRSA
Time of Perioperative Antibiotics
pg. 376
—-Pre-operative (prior to surgery)—-
DOC: 60 min before Alt: 120 min before
—-Intra-operative (during surgery)—-
Additional doses may be administered if surgery is >3-4
hours or there is major blood loss
—-Post-operative (after surgery)—-
ABX not usually needed; if used, discontinue within 24 hours
Surgery prophylaxis DOC & bug coverage
DOC: Cefazolin (1st gen ceph) - MRSA and Streptococci
Alt: Clindamycin if pt has a beta-lactam allergy or Vancomycin (MRSA colonization or risk instead of Clindamycin)
Colorectal surgery prophylaxis DOC vs alternatives & bug coverage
DOC: Cefotetan, cefoxitin, ampicillin/sulbactam (Unasyn), ertapenem, OR metronidazole PLUS cefazolin or ceftriaxone
Alt: Clindamycin PLUS (aminoglycoside, quinolone or aztreonam), OR metronidazole PLUS (aminoglycoside or quinolone)
Classic symptoms of meningitis
Fever
Headache
Stiff neck
Altered mental status
Meningitis Diagnosis & Bugs
Dx: Lumbar puncture
Bugs: S. pneumoniae, N. meningitidis, H. influenzae, Listeria
Acute Bacterial Meningitis Treatment (Community-Acquired)
ABX durations are pathogen-dependent
7 days for N. meningitidis and H. influenzae
10-14 days for S. pneumoniae
<21 days for Listeria monocytogenes
Meningitis: Empiric Treatment
Empiric antibiotic selection depends of age & RFs
Aggressive (high) doses are used to penetrate the CNS
——–Age < 1 month (neonates)——–
Ampicillin (Listeria) PLUS cefotaxime (no ceftriaxone) OR gentamicin
- ——-Age 1 month to 50 years———
- Ceftriaxone or cefotaxime PLUS vancomycin
——–Age > 50 years or immunocompromised———–
Ampicillin (Listeria) PLUS Ceftriaxone or Cefotaxime PLUS Vancomycin
Meningitis: Empiric Treatment but the adult has a severe penicillin allergy
Treat with a Quinolone (moxifloxacin) PLUS vancomycin +/- Bactrim (listeria coverage)
S/SX of AOM
Bulging tympanic (eardrum) membranes
Otorrhea (middle ear effusion/fluid)
Otalgia (ear pain)
Tugging/rubbing of ears
AOM Treatment in Kids: When to consider observation
Systemic drugs: Pain (APAP or Ibu)
Observation for 48-72 hours - non-severe AOM
-mild otalgia < 48 hours or temp <102.2F (39)
AND
Age 6-23 months: sx in one ear only
Age > 2 years: sx in one or both ears
**if sx do not improve, or worsen, use ABX
AOM Antibiotic Treatment
High-dose amoxicillin or amoxicillin/clavulanate (Augmentin)
**least amount of clavulanate - decrease risk of diarrhea
H-D covers S. pneumoniae
What is the ratio of amoxicillin to clavulanate? What’s the brand?
14:1 - Augmentin ES 600
American Academy of Pediatrics (AAP) guidelines recommended what drug class for non-severe penicillin allergy?
Cephalosporin
Treatment duration with oral medications
10 days for children < 2 years
7 days for age 2-5 years
5-7 days for age > 6 years
AOM: Antibiotic Treatment
——-First-Line Treatment———
Amoxicillin 80-90 mg/kg/day in 2 divided doses
OR
Amoxicillin/clavulanate 90 mg/kg/day
OR
Ceftriaxone IM (if vomiting or unable to tolerate PO)
——-Alternative Treatment———-
Cefdinir 14 mg/kg/d in 1-2 divided doses
Cefuroxime 30mg/kd/d in 2 divided doses
Compare and Contrast - Clinical Presentation
Common cold
Influenza
Pharyngitis
Sinusitis
pg. 379
———Clinical Presentation———–
C: sneezing, runny nose, cough
I: sudden onset fever, chills, fatigue, body aches
P: sore throat, swollen lymph nodes, white patches on tonsils
S: nasal congestion, facial/ear/dental pain, headache
Compare and Contrast - Criteria for Anti-Infective Treatment
Common cold
Influenza
Pharyngitis
Sinusitis
pg. 379
———Criteria for Anti-Infective Treatment—–
C: none
I: < 48 hours since sx onset
P: rapid antigen diagnostic test
S: > 10 days of sx OR > 3 days of severe sx (temp >102*F)
Compare and Contrast - Treatment Options
Common cold
Influenza
Pharyngitis
Sinusitis
pg. 379
C: OTC products
I: Oseltamivir x 5 days | Baloxavir x 1 dose | Zanamivir inhalation
P: Penicillin, amoxicillin
Sinusitis:
1st line - Augmentin
2nd line - PO 2nd/3rd gen ceph PLUS clindamycin, doxycycline or resp. FQ
Lower Respiratory Tract Infections - Bronchitis
Symptoms
Cause
Diagnosis
Treatment of Choice
Bronchitis
Symptoms: cough
Cause: RSV or bacteria (Bordetella pertussis ‘whooping cough’)
Diagnosis: chest x-ray
Treatment of Choice: supportive care (fluids, otc meds. abx not recommended “exception is Bordetella - macrolide or bactrim) “
COPD patient with Acute Bacterial Exacerbation of Chronic Bronchitis
- Supportive treatment (O2, short-acting inhaled
bronchodilators, IV/PO steroids) - ABX for 5-7 days if any one of the following are met:
- increase dyspnea, incr. sputum volume and incr. sputum purulence
- mechanically ventilated - Preferred ABX
- Augmentin**
- Azithromycin
- Doxycycline
Community-Acquired Pneumonia
Symptoms
Diagnosis
Common pathogens
Treatment of Choice & Duration
Community-Acquired Pneumonia
Sx: cough, purulent sputum, rales, tachypnea (incr. RR)
Dx: Chest X-ray
Bugs: S. pneumonia, H. influenzae, M. pneumoniae “walking pneumonia”
DOC: Respiratory FQs x 5-7 days
Outpatient CAP Treatment Stepwise Approach
Step 1: look for comorbidities (chronic heart, lung, liver, kidney disease, DM, alcoholism, malignancy or asplenia)
Step 2: check for MRSA or Pseudomonas
Step 3: Category 1 vs Category 2
Step 4: Choose DOC within category (look for allergies/DDIs)
Outpatient CAP Treatment Stepwise Approach
Category 1
No comorbidities
Amoxicillin H-D 1g TID OR Doxycycline OR Macrolide (Azithromycin or clarithromycin)
Outpatient CAP Treatment Stepwise Approach
Category 2
Beta-lactam PLUS macrolide OR doxycycline
- augmentin OR cephalosporin (cefpodoxime, cefuroxime) PLUS - macrolide OR doxycycline
Respiratory quinolone monotherapy - moxifloxacin, gemifloxacin, levofloxacin
Inpatient CAP treatment for nonsevere (non-ICU care)
Beta-lactam PLUS macrolide OR doxycycline
- preferred beta-lactams (Ceftriaxone, cefotaxime, ceftaroline or Unasyn)
Respiratory quinolone monotherapy
- moxifloxacin, gemifloxacin, levofloxacin
Inpatient CAP treatment for severe (ICU care)
Beta-lactam PLUS macrolide
Beta-lactam PLUS respiratory quinolones (do NOT use FQ monotherapy)
Risk factors for Pseudomonas and/or MRSA in Inpatient CAP treatment:
MRSA: add coverage with Vancomycin or Linezolid
Pseudomonas: add coverage with zosyn, cefepime, meropenem or aztreonam
Hospital-acquired pneumonia (HAP) has an onset of
onset > 48 hours after hospital admission
Ventricular-associated pneumonia (VAP) occurs
> 48 hours after the start of mechanical ventilation
Common pathogens in HAP and VAP
Nosocomial pathogens
Risk for MRSA and MDR Gram-negative rods, including Pseudomonas
HAP/VAP: Selecting an Empiric Regimen
All patients need an antibiotic for Pseudomonas and MSSA regimen:
cefepime
piperacillin/tazobactam (Zosyn)
HAP/VAP: Selecting an Empiric Regimen
If patient is at risk for MRSA what drugs are added?
Vancomycin or Linezolid
- cefepime PLUS vancomycin
- meropenem PLUS linezolid
HAP/VAP: Selecting an Empiric Regimen
What 2 antibiotics are used in Pseudomonas if risk for MDR pathogens?
-piperacillin/tazobactam PLUS ciprofloxacin PLUS
vancomycin
-cefepime PLUS gentamicin PLUS linezolid
Identify the risks for MRSA or MDR pathogens
- Positive MRSA nasal swab (indicates MRSA colonization)
- High prevalence (>10%) of pathogen resistance to any single agent noted in hospital unit
- IV antibiotic use within the past 90 days
Antibiotics for Pseudomonas (do NOT use 2 beta-lactams together)
piperacillin/tazobactam cefepime, ceftazidime, or ceftolozane/tazobactam (Zerbaxa) levofloxacin or ciprofloxacin imipenem/cilastatin or meropenem aztreonam tobramycin, gentamicin or amikacin colistimethate or polymyxin B